KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,022 | -42.8% | 76,980 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $1,871,156 | -16.8% | 81,390 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $2,250,132 | +35.9% | 75,941 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $1,656,061 | +15.6% | 64,986 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $1,432,427 | +8.0% | 65,109 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,326,103 | -48.2% | 65,825 | +7.2% | 0.00% | -50.0% |
| Q1 2022 | $2,561,070 | +128.7% | 61,413 | +246.2% | 0.00% | +100.0% |
| Q4 2021 | $1,120,000 | +10.1% | 17,739 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $1,017,000 | +29.7% | 17,316 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $784,000 | +229.4% | 16,165 | +164.4% | 0.00% | – |
| Q1 2021 | $238,000 | -36.7% | 6,114 | +0.8% | 0.00% | – |
| Q4 2020 | $376,000 | – | 6,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |